/Molecular basis of low-penetrance retinoblastoma/Clinical background 4-u1.0-B978-0-7020-2983-7..00049-8..DOCPDF Chapter 49 4-u1.0-B978-0-7020-2983-7..00049-8 4-u1.0-B978-0-7020-2983-7..00049-8 4-u1.0-B978-0-7020-2983-7..00049-8--s0015 Molecular basis of low-penetrance retinoblastoma SECTION 6 4-u1.0-B978-0-7020-2983-7..00049-8--s0010 Oncology hubsection 3 section Oncology SECTION 6 4-u1.0-B978-0-7020-2983-7..00049-8 4-u1.0-B978-0-7020-2983-7..00049-8--s0010 Molecular basis of low-penetrance retinoblastoma 4-u1.0-B978-0-7020-2983-7..X0001-0--s5 Molecular basis of low-penetrance retinoblastoma text/html; charset=ISO-8859-1 Clinical background Chapter 49 chapter bookContent 4-u1.0-B978-0-7020-2983-7..X0001-0--s5 Clinical background 4-u1.0-B978-0-7020-2983-7..00049-8 4-u1.0-B978-0-7020-2983-7..X0001-0--s5 4-u1.0-B978-0-7020-2983-7..00049-8 4-u1.0-B978-0-7020-2983-7..00048-6--fr9000 5 4-u1.0-B978-0-7020-2983-7..00049-8--s0010 Chapter 49 Ocular Disease: Mechanisms and Management 978-0-7020-2983-7 Levin and Albert 1st
Chapter 49 – Molecular basis of low-penetrance retinoblastomaKatie Matatall,
J William Harbour
Clinical backgroundRetinoblastoma is the most common intraocular malignancy in children and is the prototype inherited cancer predisposition syndrome. About 60% of new patients exhibit unilateral ocular involvement with familial inheritance pattern. The remaining patients have a heritable form of retinoblastoma, which is often associated with bilateral ocular involvement, germline transmission to offspring, and second primary tumors.[1] In most retinoblastoma families, the penetrance (the proportion of individuals with a germline mutation in the RB gene who develop clinical manifestations of the disease) is about 90%.[2] However, about one in seven families will exhibit reduced penetrance as low as 30–60%. This chapter will focus on features that are specific to low-penetrance retinoblastoma (Box 49.1). The features of retinoblastoma in general are covered in Chapter 48.
Box 49.1
| Low-penetrance retinoblastoma |
| | •
| Pathologically indistinguishable from full-penetrance retinoblastoma
| | | •
| Displays decreased penetrance and expressivity
| | | •
| Caused by distinct types of mutations in the retinoblastoma gene
|
|
The diseased-eye ratio (DER), …